Literature DB >> 6380299

Lectin receptors as markers of lymphoid cells. I. Demonstration in tissue section by peroxidase technique.

J A Strauchen.   

Abstract

The distribution of lectin binding receptors in human lymphoid tissue (lymph node and tonsil) was studied in an effort to identify lectins with potential application as cell markers. Using a simple peroxidase technique applicable to formalin-fixed, paraffin-embedded tissue, the binding properties of five lectins were investigated: concanavalin A (Con A), Arachis hypogaea (peanut agglutinin), Lotus tetragonolobus (asparagus pea), Glycine max (soybean agglutinin) and Bandeiraea simplicifolia. Three of the lectins were found to demonstrate selective binding in tissue section: Lotus tetragonolobus to transformed follicular center lymphocytes; Arachis hypogaea to transformed follicular center lymphocytes; and Con A to macrophage histiocytes. These lectins are potentially useful markers for the investigation and classification of lymphoproliferative disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6380299      PMCID: PMC1900536     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  12 in total

1.  Staining of the A antigen human erythrocytes.

Authors:  D Y Mason; C R Taylor
Journal:  J Clin Pathol       Date:  1975-07       Impact factor: 3.411

2.  Hemopoietic stem cell transplantation using mouse bone marrow and spleen cells fractionated by lectins.

Authors:  Y Reisner; L Itzicovitch; A Meshorer; N Sharon
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

3.  Lectins: cell-agglutinating and sugar-specific proteins.

Authors:  N Sharon; H Lis
Journal:  Science       Date:  1972-09-15       Impact factor: 47.728

Review 4.  The mononuclear phagocytic system: a review.

Authors:  A Lasser
Journal:  Hum Pathol       Date:  1983-02       Impact factor: 3.466

5.  Malignant histiocytosis and Letterer-Siwe disease. Neoplasms of T-zone histiocyte with S100 protein.

Authors:  S Watanabe; T Nakajima; Y Shimosato; Y Sato; K Shimizu
Journal:  Cancer       Date:  1983-04-15       Impact factor: 6.860

6.  Interaction of peanut agglutinin with normal human lymphocytes and with leukemic cells.

Authors:  Y Reisner; M Biniaminov; E Rosenthal; N Sharon; B Ramot
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

7.  Fluoresceinated lectins as probe for cell surface changes associated with lymphocyte transformation.

Authors:  J A Strauchen
Journal:  Am J Hematol       Date:  1982-05       Impact factor: 10.047

8.  Peanut lectin binding properties of germinal centres of mouse lymphoid tissue.

Authors:  M L Rose; M S Birbeck; V J Wallis; J A Forrester; A J Davies
Journal:  Nature       Date:  1980-03-27       Impact factor: 49.962

9.  Lectin staining of carbohydrates of haemic cells; the cells of normal blood and bone marrow and of the myeloid leukaemias.

Authors:  R W Stoddart; R D Collins; W Jacobson
Journal:  J Pathol       Date:  1980-08       Impact factor: 7.996

10.  Lectin histochemistry of malignant tumors. I. Peanut agglutinin (PNA) receptors in follicular lymphoma and follicular hyperplasia: an immunohistochemical study.

Authors:  H J Ree; S M Hsu
Journal:  Cancer       Date:  1983-05-01       Impact factor: 6.860

View more
  4 in total

1.  Lectins.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-30

2.  Lectin histochemistry of human bone marrow: investigation of trephine biopsy specimens in normal and reactive states and neoplastic disorders.

Authors:  U Schumacher; H P Horny; U Welsch; E Kaiserling
Journal:  Histochem J       Date:  1991-05

3.  Lectin-binding studies of a human skin mastocytoma.

Authors:  U Schumacher; H P Horny; U Welsch; E Kaiserling
Journal:  Histochem J       Date:  1989-01

4.  Lectin receptors as markers of lymphoid cells. II. Reed-Sternberg cells share lectin-binding properties of monocyte macrophages.

Authors:  J A Strauchen
Journal:  Am J Pathol       Date:  1984-09       Impact factor: 4.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.